Board of Directors

Jon Rousseau has served as our President and Chief Executive Officer and as a member of our board of directors since September 2016. Prior to joining the Company, Mr. Rousseau was an executive vice president at Kindred Healthcare, Inc. with multiple leadership roles from June 2013 – July 2016, including president of Kindred Rehabilitation Services and prior to that president of the Care Management Division and Kindred at Home, Kindred’s home health, hospice, home care and home-based primary care businesses. Before Kindred, Mr. Rousseau held a number of senior leadership positions at other market-leading healthcare product and technology companies, including vice president of global marketing, strategy, and commercial development at Mylan, Inc. and global senior director of the continuous glucose monitoring franchise with Medtronic PLC (2006 – 2013). For the first part of his career, Mr. Rousseau worked at Friedman Fleischer & Lowe LLC in private equity (1998 – 2005) and at Morgan Stanley in investment banking (1996 – 1998). He received his MBA from Harvard Business School and his A.B. degree from Princeton University. We believe Mr. Rousseau’s qualifications to serve on our board of directors include his extensive executive and leadership experience in the healthcare industry and his multi-disciplinary background.

Hunter Craig has served as a member of our board of directors since May 2020. Mr. Craig joined KKR & Co. in 2020 and is a member of the Health Care industry team within KKR & Co.’s Americas Private Equity platform. He currently serves on the Board of Directors of 123Dentist and Heartland Dental. Prior to joining KKR & Co., Mr. Craig was a vice president at GTCR (2013-2020), where he was involved in investments across the healthcare sector. He began his career as an investment banking analyst in the global industrial & services group at Credit Suisse. Mr. Craig holds a B.B.A., magna cum laude, in Accountancy and Theology from the University of Notre Dame and an M.B.A. from Harvard Business School. We believe Mr. Craig’s qualifications to serve on our board of directors include his significant business, financial, and investment experience related to the healthcare industry.

Johnny Kim has served as a member of our board of directors since 2019. Mr. Kim is a Director and has served as a member of the Health Care industry team within KKR & Co.’s Americas Private Equity platform since 2015. Mr. Kim currently serves on the Board of Directors of Argenta, Brightline, Clarify Health Solutions, Global Medical Response, SkinSpirit, and Therapy Brands. Prior to joining KKR & Co., Mr. Kim was with Goldman Sachs (2013-2015) where he was involved in a number of mergers, acquisitions, and financing transactions. He holds an Honors B.A. with distinction from the Ivey Business School, Western University and was an Ivey Scholar. We believe Mr. Kim’s qualifications to serve on our board of directors include his significant business, financial, and investment experience related to the healthcare industry.

Olivia Kirtley has been nominated to serve on our board of directors. Ms. Kirtley, a Certified Public Accountant and Chartered Global Management Accountant, has worked as a business consultant focused on strategic, risk and corporate governance issues since 2000, and prior to 2000, she served as a senior manager at a predecessor to the accounting firm Ernst & Young LLP and as chief financial officer and treasurer of Vermont American Corporation. Ms. Kirtley served as President and Chairman of the International Federation of Accountants (2014-2016), and also served as Chairman of the American Institute of Certified Public Accountants, or AICPA (1998-1999), and Chairman of the AICPA Board of Examiners. Ms. Kirtley has served on the board of Vista Credit Strategic Lending Corp. since 2023, and previously served on the board of Papa John’s International (2003-2023), on the board of U.S. Bancorp (2006-2023), on the board of Rangold Resources Ltd (2017-2019) and on the board of a predecessor of the Company, ResCare, Inc. (1998-2019). She holds a B.S. in Accounting from Florida Southern College, and a Master’s Degree in Taxation from Georgia State University. We believe Ms. Kirtley’s qualifications to serve on our board of directors include her extensive audit, financial reporting, and risk management experience and experience serving on public company boards.

Max Lin has served as a member of our board of directors since 2017. Mr. Lin is a Partner at KKR & Co. where he leads the Health Care industry team within its Americas Private Equity platform and serves as a member of the Investment Committee and Portfolio Management Committee for Americas Private Equity, the Health Care Strategic Growth Investment Committee, and the Global Conflicts and Compliance Committee. Mr. Lin was involved in KKR & Co.’s investments in 123 Dentist, Coherus BioSciences, Covenant Physician Partners, Envision Healthcare, Global Medical Response, HCA, Heartland Dental, PetVet Care Centers, PRA Health Sciences, Therapy Brands, and Zimmer Biomet, among others. Prior to joining KKR & Co., Mr. Lin was with Morgan Stanley where he was involved in a number of mergers, acquisitions, and financing transactions. He holds a B.S. and B.A.S., summa cum laude, from the University of Pennsylvania and an M.B.A. from Harvard Business School. We believe Mr. Lin’s qualifications to serve on our board of directors include his significant business, financial, and investment experience related to the healthcare industry and prior involvement with KKR Stockholder’s investment in the Company.

Dr. Steve Miller has been nominated to serve on our board of directors. Dr. Steve Miller has been a trusted expert and advisor for Cigna’s efforts across clinical policy, quality and performance programs since 2022 after serving as the company’s Chief Clinical Officer for nearly five years. He formerly served as Express Scripts’ Senior Vice President and Chief Medical Officer, responsible for supporting government relations, leading the Pharmacy & Therapeutics committee, managing the Medical Affairs team, leading Government Affairs and interfacing with client groups. During his 12 years in that position, Dr. Miller focused on improving health outcomes and value through e-prescribing initiatives, specialty solutions and overall product development. 

Dr. Miller’s expertise represents years as a medical researcher, clinician and administrator, and spans numerous healthcare subjects. He previously was the vice president and chief medical officer at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis. Dr. Miller received his medical degree from the University of Missouri-Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham. He was the William J. and Dorothy Fish Kerr Fellow in Cardiology at the University of California, San Francisco. Dr. Miller also did Internal Medicine training at the University of Colorado and Nephrology and Transplantation at Washington University in St. Louis. He earned his MBA at the Olin School of Business at Washington University.

Tim Wicks was at UnitedHealth Group (UNH) until his retirement in 2021. During his nearly 20 years at the company he held a broad range of executive leadership positions, including executive oversight for Optum Financial (the largest healthcare-focused bank and financial services firm in the US with over $15B in assets), chief financial officer of Optum ($120B+ revenue), head of supply chain, then president and chief executive officer of OptumRx ($60B+ revenue), and various leadership roles in operations, product management, business development and strategic relationships at both UnitedHealthcare and Optum. Tim was also a board member of Optum360, Optum’s joint venture in Revenue Cycle Management with external partners CommonSpirit and Northwell.

Previously, Tim was chief financial officer, and president and chief operating officer of Yellow Corp ($5B revenue), the holding company for trucking carriers YRC Freight, New Penn, Holland and Reddaway, and freight brokerage HNRY Logistics. He has held executive positions at Dell Technologies, Bain & Company, and Northwest Airlines. In addition, Tim co-founded a registered investment advisory firm that developed quantitative investment strategies for institutional clients.

Tim has served on the boards of four public companies: BrightSpring Health, Precision Castparts Corp (sold to Berkshire Hathaway for $37B), Aerojet Rocketdyne, and Pear Therapeutics. He served on the finance and audit committees of each company and is an SEC Financial Expert; he also serves on the compensation committee of BrightSpring.

Tim serves on the board of directors, and chairs the advisory board of MOBE, a privately held company, and he also is actively engaged supporting the growth of several private companies. Tim serves as an Advisor to the CEO of Hope for the Child, a not-for-profit that has provided early primary education and welfare for over 7000 highly needy children in Kenya.

Tim earned a BA in economics, with honors, from the University of Chicago and an MBA from Harvard University’s Graduate School of Business.